PHARMACOKINETIC STUDIES OF IN-SITU LIPOSOMAL PREPARATION CONTAINING AMPHOTERICIN B COMPLEXED WITH DIFFERENT CHEMICALLY MODIFIED β-CYCLODEXTRINS

REFERENCES

• Janknegt R., DeMarie S., Bakker-Woudenberg I. A.J.M., Crommelin D. J.A. Liposomal and lipid formulations of Pharmacokinetics 1992; 23: 279–91
   Google Scholar
• Khoo S. H., Bond J., Denning D. W. Administering amphotericin B a practical approach. Journal of Antimicrobial Chemotherapy 1994; 33: 203–213
   PubMed Web of Science ®Google Scholar
• De Marie S., Janknegt R., Bakker-Woudenberg I. A.J.M. Clinical use of liposomal and lipid complexed amphotericin B. Journal of Antimicrobial Chemotherapy 1994; 33: 907–916
   PubMedGoogle Scholar
• Kirsch R., Goldstein R., Tarloff J., Parris D, Hook J, Hanna N. An emulsion formulation of amphotericin-B improves the therapeutic index when treating systemic murine candidiasis. Journal of Infectious Diseases 1998; 158: 1065–70
   Google Scholar
• Washington C., Lance M., Davis S. S. Toxicity of Amphotericin B emulsion formulations. Journal of Antimicrobial Chemotherapy 1993; 31: 806–8
   PubMed Web of Science ®Google Scholar
• Konsberg B., Dahlman A., Carlfors J., Karlsson J. Preparation and evaluation of sterically stabilized liposomes: colloidal stability, serum stability, Macrophage uptake and Toxicity. Journal of Pharm. Sci. 1990; 79(B)667–671
   PubMedGoogle Scholar
• Perrett S., Golding M, Williams W. P. A simple method for the preparation of liposomes for pharmaceutical applications : Characterization of the liposomes. J. Pharm. Pharmacol. 1991; 43: 154–161
   PubMed Web of Science ®Google Scholar
• McCormack B., Gregoriadis B. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-B-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. Biochimica at Biophysica Acta 1996; 1291: 237–244
   PubMed Web of Science ®Google Scholar
• Masson M., Loftsson T., Jonsdottir S., Fridriksdottir H., Petersen D. S. Stabilization of ionic drugs through complexation with nonionic and ionic cyclodextrin. Int. J. Pharm 1998; 164(1-2)45–55
   Web of Science ®Google Scholar
• Chakraborty K. K., Naik S. R. In-situ liposomal preparation containing amphotericin-B and its related toxicity and tissue disposition studies. Pharmaceutical development and Technology 1999; 5(4)543–553
   Google Scholar
• Hunter W. M. Handbook of experimental Immunology. Blackwell Sci., Oxford
   Google Scholar
• Surolia A, Bachhawat B. K, Podder S. K. Interaction between lectin from ricinus communis and liposomes containing gangliosides. Nature 1975; 257: 802–804
   PubMed Web of Science ®Google Scholar
• Adhage N. A., Vavia P. R. Grinding: A method for β-cyclodextrin inclusion complexation. 17th Asian Congress of Pharmaceutical Sciences. December, 10–13. Mumbai (Bombay)India 1998; 58
   Google Scholar
• Giron D. Thermal analysis of drugs and products, encyclopedia of Pharmaceutical Technology, J. Swarbic, J. C. Boylan. Marcel Dekker Inc., New York 1997; 15: 56–58
   Google Scholar
• Vaskovsky V. E., Kostetsky E. Y., Vasendin I. M. A Universal reagent for phospholipid analysis. J. Chromatogr. 1975; 114: 129–141
   PubMed Web of Science ®Google Scholar
• Nilsson-Ehle I., Yoshikawa T. T., Edwards J. E., Schotz M. C., Guze L. B. Quantitation of amphotericin–B with use of high pressure liquid chromatography. Journal of Infectious Diseases 1997; 135: 414–422
   Google Scholar
• Gibaldi M., Parrier D. Non-compartmental analysis based on statistical moment theory. Pharmaco, J. Swarbick. Marcel Dekker Inc., , Newyork, 409–416
   Google Scholar
• Snedecor G. W., Cochran W. G. Statistical method. Oxford, & IBH Publ. Co. India. 1968; 227–279
   Google Scholar
• Loftsson T., Brester M. E. Pharmaceutical applications of cyclodextrin. Drug solubilization and stabilization. J. Pharm. Sci. 1996; 85(10)1017–1025
   PubMed Web of Science ®Google Scholar
• Irie T., Uekama K. Pharmaceutical application of cyclodextrin (III)–Toxicological issues and safety evaluation. Journal of Pharmaceutical Sciences 1997; 86(No. 2)147–162
   PubMedGoogle Scholar
• Tottermann A. M., Schippr N., Thompson D., Mannermaa J. P. Effects of Water Soluble B-CD on the permeability of human intestinal epithelial (CaCO-2) cells. Conference on the formulation of poorly available drugs for oral administration, ParisFrance, February, 5–6, 151
   Google Scholar
• Rapp R. P., Gubbins P. O., Evans M. E. Amphotericin-B Lipid Complex, the annals of Pharmacotherapy 1997; 31: 1174–1186
   PubMedGoogle Scholar
• Dave J., Patel H. M. Differentiation in hepatic and splenic phagocytic activity during reticuloendothelial blockade with cholesterol-free and cholesterol-rich liposomes. Biochim. Biophys. Acta 1986; 888: 184–190
   PubMedGoogle Scholar
• Proffitt R. T., Williams L. E., Presant C. A., Tin G. W. Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles. Science 1983; 220: 502–540
   PubMed Web of Science ®Google Scholar
• Chakraborty K. K., Naik S. R. Pharmacokinetic analysis of In-Situ liposomal preparation derived from proliposome, Symposium on Natural origin substances in drug formulation. BeijingChina, November, 4 to 6, 1998; 49–50
   Google Scholar
• De-Chasteign S., Fessi H., Devissaguet J. P., Puisieusx F. comparative study of the association of Itraconazole with colloidal drug carrier. Drug Dev. Res. 1996; 38(2)125–133
   Web of Science ®Google Scholar
• Zia V., Bornancini E. R., Luna E. A., Rajewaki R. A., Stella V. J. Sulfoalkyl ether BCDS: effects of alkyl chain length and degree of substitution on complexation, AAPS. Tenth Annual meeting and Exposition, Miami Beach, Florida, November, 5–9, 127
   Google Scholar
• Okimoto K., Rajewski R. A., Jona J. A., Stella V. J. The interaction of charged and uncharged drugs with a neutral (HPBCD) and anionically charged (SBE7-BCD) BCD, AAPS. Tenth Annual meeting and Exposition, Miami Beach, Florida, November, 5–9, 1995; 130
   Google Scholar